AQXENA
LIVE

Serial Number

79298070

Owner

MITSUI KNOWLEDGE INDUSTRY CO., LTD.

Attorney

Flavia Campbell

Filing Date

Jul 17, 2020

Add to watchlist:

No watchlists yet
View on USPTO

AQXENA Trademark

Serial Number: 79298070 • Registration: 6392049

AQXENA is a trademark filed by MITSUI KNOWLEDGE INDUSTRY CO., LTD. on July 17, 2020. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MITSUI KNOWLEDGE INDUSTRY CO., LTD. (8 trademarks)

2-5-1 Atago,

Entity Type: 03

Trademark Details

Filing Date

July 17, 2020

Registration Date

June 22, 2021

Published for Opposition

April 6, 2021

Goods & Services

Downloadable computer software used for evaluation, assessment and analysis of pharmacokinetics in developing pharmaceutical preparations and substances; recorded computer software used for evaluation, assessment and analysis of pharmacokinetics in developing pharmaceutical preparations and substances ; Downloadable computer software used for measuring, analyzing, assessing and evaluating configuration of nucleic acid molecule; recorded computer software used for measuring, analyzing, assessing and evaluating configuration of nucleic acid molecule ; Downloadable computer software used for analyzing, assessing and evaluating data from mass analyzers; recorded computer software used for analyzing, assessing and evaluating data from mass analyzers

Providing temporary use of online non-downloadable computer software used for evaluation, assessment and analysis of pharmacokinetics in developing pharmaceutical preparations and substances; providing temporary use of online non-downloadable computer software used for measuring, analyzing, assessing and evaluating configuration of nucleic acid molecule; providing temporary use of online non-downloadable computer software used for analyzing, assessing and evaluating data from mass analyzers; maintenance, design and upgrade of computer software used for evaluation, assessment and analysis of pharmacokinetics in developing pharmaceutical preparations and substances; maintenance, design and upgrade of computer software used for measuring, analyzing, assessing and evaluating configuration of nucleic acid molecule; maintenance, design and upgrade of computer software used for analyzing, assessing and evaluating data from mass analyzers; data analysis services, namely, data analysis of pharmacokinetics for scientific research purposes, data analysis in the field of nucleic acid molecule for scientific research purposes, and analysis of data from mass analyzers for scientific research purpose; computer-aided scientific research, testing and analysis services in the field of mass analysis data of nucleic acid; computerized electronic storage of data log relating to mass analysis data of nucleic acid; analyzing of data of mass of nucleic acid for scientific research purposes and electronic storage of data log

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jun 22, 2026 REM3
CHANGE OF NAME/ADDRESS REC'D FROM IB
May 28, 2026 ADCH
NEW REPRESENTATIVE AT IB RECEIVED
Apr 23, 2026 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Nov 4, 2021 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Oct 13, 2021 FICS
FINAL DISPOSITION PROCESSED
Oct 13, 2021 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Sep 22, 2021 FICR
REGISTERED-PRINCIPAL REGISTER
Jun 22, 2021 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Apr 6, 2021 NPUB
PUBLISHED FOR OPPOSITION
Apr 6, 2021 PUBO
NOTIFICATION PROCESSED BY IB
Apr 5, 2021 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Mar 17, 2021 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Mar 17, 2021 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 17, 2021 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 26, 2021 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 18, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 18, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 18, 2021 TROA
REFUSAL PROCESSED BY IB
Feb 14, 2021 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jan 28, 2021 RFCS
REFUSAL PROCESSED BY MPU
Jan 28, 2021 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jan 9, 2021 RFCR
NON-FINAL ACTION WRITTEN
Jan 8, 2021 CNRT
APPLICATION FILING RECEIPT MAILED
Jan 8, 2021 MAFR
ASSIGNED TO EXAMINER
Jan 4, 2021 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 4, 2021 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Dec 31, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 19, 2020 REPR